Related Experiment Video
Updated: Jul 19, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Screening for serious mental illness in populations with co-occurring substance use disorders: Performance of the K6
James A Swartz1, Arthur J Lurigio
1Jane Addams College of Social Work, University of Illinois at Chicago, Chicago, IL 60607, USA. jaswartz@uic.edu
Abstract:
Serious mental illnesses (SMIs) such as schizophrenia, bipolar disorder, and major depression are prevalent among individuals with substance use disorders, particularly those in drug treatment programs. No screening tool has yet become the gold standard for identifying SMI among individuals with substance use disorders. One candidate instrument, the K6 screening scale, is brief, easy to administer and score, and has performed well, detecting SMI in studies using general population samples. We used data from the National Survey on Drug Use and Health to examine the K6's psychometric properties in a subsample of persons with substance use disorders and found that the K6 accurately screened for severe psychological distress associated with SMI among individuals with substance use disorders and across different psychiatric disorders.
Related Concept Videos
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Self-Report Tests of Personality
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
